Page 2 - Hans Kolam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hans kolam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hans Kolam Today - Breaking & Trending Today

Active Biotech strengthens the patent protection for laquinimod in eye disorders

Lund, April 26, 2022, Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the European Patent Office (EPO) has issued a decision to grant Active Biotech's patent related to use of laquinimod as ....

Hans Kolam , Helen Tuvesson , European Patent Office , Us Patent Office , Active Biotech ,

Active Biotech Interim Report Q1 2022

FIRST QUARTER IN BRIEF Dr. Erik Vahtola appointed Chief Medical Officer (Jan 01)First patient dosed in the combination part of the phase Ib/IIa study of tasquinimod in multiple myeloma (Feb 07)Active ....

Hans Kolam , Erik Vahtola , Loncode Institute , Chief Medical Officer ,

Active Biotech Interim Report Q1 2022

FIRST QUARTER IN BRIEF Dr. Erik Vahtola appointed Chief Medical Officer First patient dosed in the combination part of the phase Ib/IIa study of tasquinimod in multiple myeloma Active Biotech. ....

Hans Kolam , Erik Vahtola , Loncode Institute , Eu Press , Chief Medical Officer ,

Number of shares and votes in Active Biotech

The number of shares and votes in Active Biotech has changed as a result of allotment of performance shares under the company's incentive program for the company's employees (Plan 2020/2024). Today ....

Hans Kolam , Active Biotech , Financial Instruments Trading ,